test

Michael Kramarz

@Commodore Capital Lp

Latest period2024 - Q3ReportedManaged Assets$1.6BTotal holdings36
Assets growth rate9.24%Assets growth rate (2-Q avg)3.6%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Commodore Capital Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 36 positions.

Assets under management

The assets under management (AUM) of Commodore Capital Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.6B in assets, with a quarterly growth rate of 9.24% and a 2-quarter average growth rate of 3.6%. The portfolio is managed by Michael Kramarz, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
CELCCelcuity Inc
Recent Activity
Increased 3.98%
1.42%
$22.698M
1.522M shares@ $14.91 avg price
CNTACentessa Pharmaceuticals Plc
Recent Activity
New Position
1.35%
$21.587M
1.35M shares@ $15.99 avg price
NKTXNkarta Inc
Recent Activity
Increased 12.32%
1.32%
$21.073M
4.662M shares@ $4.53 avg price
ORICOric Pharmaceuticals Inc
Recent Activity
1.29%
$20.5M
2M shares@ $10.25 avg price
CCCCC4 Therapeutics Inc
Recent Activity
1.22%
$19.439M
3.41M shares@ $5.71 avg price
THRDThird Harmonic Bio Inc
Recent Activity
Decreased -11.96%
1.16%
$18.436M
1.361M shares@ $13.56 avg price
SNDXSyndax Pharmaceuticals Inc
Recent Activity
Increased 7.28%
1.07%
$17.036M
885,000 shares@ $19.25 avg price
APGEApogee Therapeutics Inc
Recent Activity
1.07%
$17.035M
290,000 shares@ $58.74 avg price
ABVXAbivax Sa
Recent Activity
0.93%
$14.793M
1.284M shares@ $11.52 avg price
TILInstil Bio Inc
Recent Activity
New Position
0.64%
$10.161M
150,929 shares@ $67.32 avg price